Characteristic | Number (n = 10) | % |
---|---|---|
Age in years, mean (range) | 67 (48–79) |  |
Biopsy of primary tumour | Â | Â |
 ER+/AR+ | 10 | 100 |
Biopsy of metastases | ||
 ER+/AR+ | 8 | 80 |
 ER+/AR- | 1 | 10 |
 ER−/AR− | 1 | 10 |
Previous treatment lines | ||
 0–1 | 3 | 30 |
 2–4 | 7 | 70 |
Visible lesions: total, median per patient (range) | 120, 9 (2–32) |  |
 Conventional imaging (CT, bone scan) | 69 (54, 40) | 58 (45, 33) |
 Visible on PET alone ([18F]FES or [18F]FDHT PET) | 51 (33, 20) | 42 (28, 16) |
  Total visible on [18F]FES PET (observer 1, 2) | 64, 69 | 53, 58 |
  Total visible on [18F]FDHT PET (observer 1, 2) | 36, 37 | 30, 31 |
Location | ||
 Bone (conventional imaging, [18F]FES, [18F]FDHT PET) | 79 (55, 45, 37) | 66 (80, 54, 64) |
 Lymph node (conventional imaging, [18F]FES; [18F]FDHT PET) | 30 (8, 29, 16) | 25 (12, 35, 28) |
 Viscerala (conventional imaging, [18F]FES, [18F]FDHT PET) | 11 (6, 9, 5) | 9 (9, 11, 9) |